The global market for Bacteriophages Antimicrobials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Bacteriophages, often simply called phages, are viruses that infect and replicate within bacteria. Bacteriophages are natural enemies of bacteria, and they can be harnessed for their antimicrobial properties. Bacteriophages are specific to bacteria, and each type of phage typically infects only a particular strain or species of bacteria.

Bacteriophages infect bacteria by attaching to specific receptors on the bacterial cell surface. Once attached, the phage injects its genetic material into the bacterium, taking over the bacterial machinery to replicate and produce new phage particles. As the new phage particles are produced, they eventually cause the bacterial cell to burst or lyse, releasing the newly formed phages. This process results in the destruction of the bacterial cell.

One of the key advantages of bacteriophages is their specificity. Each type of phage has a narrow host range, meaning it can only infect certain types or strains of bacteria. This specificity allows for targeted antimicrobial action without affecting non-bacterial cells, including human cells.

Bacteriophages have been explored as potential therapeutic agents against bacterial infections. This approach, known as phage therapy, involves using specific phages to target and kill pathogenic bacteria. Phage therapy has been investigated as an alternative or complementary treatment to antibiotics. Bacteriophages are used in the food industry to control bacterial contamination. They can be applied to foods to target and reduce the levels of harmful bacteria, improving food safety.

North American market for Bacteriophages Antimicrobials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Bacteriophages Antimicrobials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Bacteriophages Antimicrobials include Vésale Bioscience, Adaptive Phage Therapeutics, Proteon Pharmaceuticals, PHIOGEN, Phageguard, Armata Pharmaceuticals, ACD Pharmaceuticals, SyntBioLab, Antibody Design Labs, APS Biocontrol, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bacteriophages Antimicrobials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophages Antimicrobials.

The Bacteriophages Antimicrobials market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacteriophages Antimicrobials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bacteriophages Antimicrobials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bacteriophages Antimicrobials Market Report

Report Metric	Details
Report Name	Bacteriophages Antimicrobials Market
by End Users	by Genome
Segment by Application	Medical Food Industry Agriculture Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Vésale Bioscience, Adaptive Phage Therapeutics, Proteon Pharmaceuticals, PHIOGEN, Phageguard, Armata Pharmaceuticals, ACD Pharmaceuticals, SyntBioLab, Antibody Design Labs, APS Biocontrol, BiomX, EcoPhage, Ecolyse, Fixed Phage, Intralytix, Locus Biosciences, Micreos, OmniLytics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacteriophages Antimicrobials manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacteriophages Antimicrobials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bacteriophages Antimicrobials Market report?

Ans: The main players in the Bacteriophages Antimicrobials Market are Vésale Bioscience, Adaptive Phage Therapeutics, Proteon Pharmaceuticals, PHIOGEN, Phageguard, Armata Pharmaceuticals, ACD Pharmaceuticals, SyntBioLab, Antibody Design Labs, APS Biocontrol, BiomX, EcoPhage, Ecolyse, Fixed Phage, Intralytix, Locus Biosciences, Micreos, OmniLytics

What are the Application segmentation covered in the Bacteriophages Antimicrobials Market report?

Ans: The Applications covered in the Bacteriophages Antimicrobials Market report are Medical, Food Industry, Agriculture, Others

What are the End User segmentation covered in the Bacteriophages Antimicrobials Market report?

Ans: The End users covered in the Bacteriophages Antimicrobials Market report are by Genome

1 Bacteriophages Antimicrobials Market Overview

1.1 Product Definition

1.2 Bacteriophages Antimicrobials by Type

1.2.1 Global Bacteriophages Antimicrobials Market Value Comparison by Type (2024 VS 2031)

1.2.2 by End Users

1.2.3 by Genome

1.3 Bacteriophages Antimicrobials by Application

1.3.1 Global Bacteriophages Antimicrobials Market Value by Application (2024 VS 2031)

1.3.2 Medical

1.3.3 Food Industry

1.3.4 Agriculture

1.3.5 Others

1.4 Global Bacteriophages Antimicrobials Market Size Estimates and Forecasts

1.4.1 Global Bacteriophages Antimicrobials Revenue 2020-2031

1.4.2 Global Bacteriophages Antimicrobials Sales 2020-2031

1.4.3 Global Bacteriophages Antimicrobials Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Bacteriophages Antimicrobials Market Competition by Manufacturers

2.1 Global Bacteriophages Antimicrobials Sales Market Share by Manufacturers (2020-2025)

2.2 Global Bacteriophages Antimicrobials Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Bacteriophages Antimicrobials Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Bacteriophages Antimicrobials, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Bacteriophages Antimicrobials, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Bacteriophages Antimicrobials, Product Type & Application

2.7 Global Key Manufacturers of Bacteriophages Antimicrobials, Date of Enter into This Industry

2.8 Global Bacteriophages Antimicrobials Market Competitive Situation and Trends

2.8.1 Global Bacteriophages Antimicrobials Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Bacteriophages Antimicrobials Players Market Share by Revenue

2.8.3 Global Bacteriophages Antimicrobials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Bacteriophages Antimicrobials Market Scenario by Region

3.1 Global Bacteriophages Antimicrobials Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Bacteriophages Antimicrobials Sales by Region: 2020-2031

3.2.1 Global Bacteriophages Antimicrobials Sales by Region: 2020-2025

3.2.2 Global Bacteriophages Antimicrobials Sales by Region: 2026-2031

3.3 Global Bacteriophages Antimicrobials Revenue by Region: 2020-2031

3.3.1 Global Bacteriophages Antimicrobials Revenue by Region: 2020-2025

3.3.2 Global Bacteriophages Antimicrobials Revenue by Region: 2026-2031

3.4 North America Bacteriophages Antimicrobials Market Facts & Figures by Country

3.4.1 North America Bacteriophages Antimicrobials Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Bacteriophages Antimicrobials Sales by Country (2020-2031)

3.4.3 North America Bacteriophages Antimicrobials Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Bacteriophages Antimicrobials Market Facts & Figures by Country

3.5.1 Europe Bacteriophages Antimicrobials Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Bacteriophages Antimicrobials Sales by Country (2020-2031)

3.5.3 Europe Bacteriophages Antimicrobials Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Bacteriophages Antimicrobials Market Facts & Figures by Region

3.6.1 Asia Pacific Bacteriophages Antimicrobials Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Bacteriophages Antimicrobials Sales by Region (2020-2031)

3.6.3 Asia Pacific Bacteriophages Antimicrobials Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Bacteriophages Antimicrobials Market Facts & Figures by Country

3.7.1 Latin America Bacteriophages Antimicrobials Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Bacteriophages Antimicrobials Sales by Country (2020-2031)

3.7.3 Latin America Bacteriophages Antimicrobials Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Bacteriophages Antimicrobials Market Facts & Figures by Country

3.8.1 Middle East and Africa Bacteriophages Antimicrobials Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Bacteriophages Antimicrobials Sales by Country (2020-2031)

3.8.3 Middle East and Africa Bacteriophages Antimicrobials Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Bacteriophages Antimicrobials Sales by Type (2020-2031)

4.1.1 Global Bacteriophages Antimicrobials Sales by Type (2020-2025)

4.1.2 Global Bacteriophages Antimicrobials Sales by Type (2026-2031)

4.1.3 Global Bacteriophages Antimicrobials Sales Market Share by Type (2020-2031)

4.2 Global Bacteriophages Antimicrobials Revenue by Type (2020-2031)

4.2.1 Global Bacteriophages Antimicrobials Revenue by Type (2020-2025)

4.2.2 Global Bacteriophages Antimicrobials Revenue by Type (2026-2031)

4.2.3 Global Bacteriophages Antimicrobials Revenue Market Share by Type (2020-2031)

4.3 Global Bacteriophages Antimicrobials Price by Type (2020-2031)

5 Segment by Application

5.1 Global Bacteriophages Antimicrobials Sales by Application (2020-2031)

5.1.1 Global Bacteriophages Antimicrobials Sales by Application (2020-2025)

5.1.2 Global Bacteriophages Antimicrobials Sales by Application (2026-2031)

5.1.3 Global Bacteriophages Antimicrobials Sales Market Share by Application (2020-2031)

5.2 Global Bacteriophages Antimicrobials Revenue by Application (2020-2031)

5.2.1 Global Bacteriophages Antimicrobials Revenue by Application (2020-2025)

5.2.2 Global Bacteriophages Antimicrobials Revenue by Application (2026-2031)

5.2.3 Global Bacteriophages Antimicrobials Revenue Market Share by Application (2020-2031)

5.3 Global Bacteriophages Antimicrobials Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Vésale Bioscience

6.1.1 Vésale Bioscience Company Information

6.1.2 Vésale Bioscience Description and Business Overview

6.1.3 Vésale Bioscience Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Vésale Bioscience Bacteriophages Antimicrobials Product Portfolio

6.1.5 Vésale Bioscience Recent Developments/Updates

6.2 Adaptive Phage Therapeutics

6.2.1 Adaptive Phage Therapeutics Company Information

6.2.2 Adaptive Phage Therapeutics Description and Business Overview

6.2.3 Adaptive Phage Therapeutics Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Adaptive Phage Therapeutics Bacteriophages Antimicrobials Product Portfolio

6.2.5 Adaptive Phage Therapeutics Recent Developments/Updates

6.3 Proteon Pharmaceuticals

6.3.1 Proteon Pharmaceuticals Company Information

6.3.2 Proteon Pharmaceuticals Description and Business Overview

6.3.3 Proteon Pharmaceuticals Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Proteon Pharmaceuticals Bacteriophages Antimicrobials Product Portfolio

6.3.5 Proteon Pharmaceuticals Recent Developments/Updates

6.4 PHIOGEN

6.4.1 PHIOGEN Company Information

6.4.2 PHIOGEN Description and Business Overview

6.4.3 PHIOGEN Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.4.4 PHIOGEN Bacteriophages Antimicrobials Product Portfolio

6.4.5 PHIOGEN Recent Developments/Updates

6.5 Phageguard

6.5.1 Phageguard Company Information

6.5.2 Phageguard Description and Business Overview

6.5.3 Phageguard Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Phageguard Bacteriophages Antimicrobials Product Portfolio

6.5.5 Phageguard Recent Developments/Updates

6.6 Armata Pharmaceuticals

6.6.1 Armata Pharmaceuticals Company Information

6.6.2 Armata Pharmaceuticals Description and Business Overview

6.6.3 Armata Pharmaceuticals Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Armata Pharmaceuticals Bacteriophages Antimicrobials Product Portfolio

6.6.5 Armata Pharmaceuticals Recent Developments/Updates

6.7 ACD Pharmaceuticals

6.7.1 ACD Pharmaceuticals Company Information

6.7.2 ACD Pharmaceuticals Description and Business Overview

6.7.3 ACD Pharmaceuticals Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.7.4 ACD Pharmaceuticals Bacteriophages Antimicrobials Product Portfolio

6.7.5 ACD Pharmaceuticals Recent Developments/Updates

6.8 SyntBioLab

6.8.1 SyntBioLab Company Information

6.8.2 SyntBioLab Description and Business Overview

6.8.3 SyntBioLab Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.8.4 SyntBioLab Bacteriophages Antimicrobials Product Portfolio

6.8.5 SyntBioLab Recent Developments/Updates

6.9 Antibody Design Labs

6.9.1 Antibody Design Labs Company Information

6.9.2 Antibody Design Labs Description and Business Overview

6.9.3 Antibody Design Labs Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Antibody Design Labs Bacteriophages Antimicrobials Product Portfolio

6.9.5 Antibody Design Labs Recent Developments/Updates

6.10 APS Biocontrol

6.10.1 APS Biocontrol Company Information

6.10.2 APS Biocontrol Description and Business Overview

6.10.3 APS Biocontrol Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.10.4 APS Biocontrol Bacteriophages Antimicrobials Product Portfolio

6.10.5 APS Biocontrol Recent Developments/Updates

6.11 BiomX

6.11.1 BiomX Company Information

6.11.2 BiomX Description and Business Overview

6.11.3 BiomX Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.11.4 BiomX Bacteriophages Antimicrobials Product Portfolio

6.11.5 BiomX Recent Developments/Updates

6.12 EcoPhage

6.12.1 EcoPhage Company Information

6.12.2 EcoPhage Description and Business Overview

6.12.3 EcoPhage Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.12.4 EcoPhage Bacteriophages Antimicrobials Product Portfolio

6.12.5 EcoPhage Recent Developments/Updates

6.13 Ecolyse

6.13.1 Ecolyse Company Information

6.13.2 Ecolyse Description and Business Overview

6.13.3 Ecolyse Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Ecolyse Bacteriophages Antimicrobials Product Portfolio

6.13.5 Ecolyse Recent Developments/Updates

6.14 Fixed Phage

6.14.1 Fixed Phage Company Information

6.14.2 Fixed Phage Description and Business Overview

6.14.3 Fixed Phage Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Fixed Phage Bacteriophages Antimicrobials Product Portfolio

6.14.5 Fixed Phage Recent Developments/Updates

6.15 Intralytix

6.15.1 Intralytix Company Information

6.15.2 Intralytix Description and Business Overview

6.15.3 Intralytix Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Intralytix Bacteriophages Antimicrobials Product Portfolio

6.15.5 Intralytix Recent Developments/Updates

6.16 Locus Biosciences

6.16.1 Locus Biosciences Company Information

6.16.2 Locus Biosciences Description and Business Overview

6.16.3 Locus Biosciences Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Locus Biosciences Bacteriophages Antimicrobials Product Portfolio

6.16.5 Locus Biosciences Recent Developments/Updates

6.17 Micreos

6.17.1 Micreos Company Information

6.17.2 Micreos Description and Business Overview

6.17.3 Micreos Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Micreos Bacteriophages Antimicrobials Product Portfolio

6.17.5 Micreos Recent Developments/Updates

6.18 OmniLytics

6.18.1 OmniLytics Company Information

6.18.2 OmniLytics Description and Business Overview

6.18.3 OmniLytics Bacteriophages Antimicrobials Sales, Revenue and Gross Margin (2020-2025)

6.18.4 OmniLytics Bacteriophages Antimicrobials Product Portfolio

6.18.5 OmniLytics Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Bacteriophages Antimicrobials Industry Chain Analysis

7.2 Bacteriophages Antimicrobials Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Bacteriophages Antimicrobials Production Mode & Process Analysis

7.4 Bacteriophages Antimicrobials Sales and Marketing

7.4.1 Bacteriophages Antimicrobials Sales Channels

7.4.2 Bacteriophages Antimicrobials Distributors

7.5 Bacteriophages Antimicrobials Customer Analysis

8 Bacteriophages Antimicrobials Market Dynamics

8.1 Bacteriophages Antimicrobials Industry Trends

8.2 Bacteriophages Antimicrobials Market Drivers

8.3 Bacteriophages Antimicrobials Market Challenges

8.4 Bacteriophages Antimicrobials Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Adaptive Phage Therapeutics

Proteon Pharmaceuticals

Armata Pharmaceuticals

List of Tables

Table 1. Global Bacteriophages Antimicrobials Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Bacteriophages Antimicrobials Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Bacteriophages Antimicrobials Market Competitive Situation by Manufacturers in 2024

Table 4. Global Bacteriophages Antimicrobials Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Bacteriophages Antimicrobials Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Bacteriophages Antimicrobials Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Bacteriophages Antimicrobials Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Bacteriophages Antimicrobials Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Bacteriophages Antimicrobials, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Bacteriophages Antimicrobials, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Bacteriophages Antimicrobials, Product Type & Application

Table 12. Global Key Manufacturers of Bacteriophages Antimicrobials, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Bacteriophages Antimicrobials by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophages Antimicrobials as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Bacteriophages Antimicrobials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Bacteriophages Antimicrobials Sales by Region (2020-2025) & (K Units)

Table 18. Global Bacteriophages Antimicrobials Sales Market Share by Region (2020-2025)

Table 19. Global Bacteriophages Antimicrobials Sales by Region (2026-2031) & (K Units)

Table 20. Global Bacteriophages Antimicrobials Sales Market Share by Region (2026-2031)

Table 21. Global Bacteriophages Antimicrobials Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Bacteriophages Antimicrobials Revenue Market Share by Region (2020-2025)

Table 23. Global Bacteriophages Antimicrobials Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Bacteriophages Antimicrobials Revenue Market Share by Region (2026-2031)

Table 25. North America Bacteriophages Antimicrobials Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Bacteriophages Antimicrobials Sales by Country (2020-2025) & (K Units)

Table 27. North America Bacteriophages Antimicrobials Sales by Country (2026-2031) & (K Units)

Table 28. North America Bacteriophages Antimicrobials Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Bacteriophages Antimicrobials Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Bacteriophages Antimicrobials Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Bacteriophages Antimicrobials Sales by Country (2020-2025) & (K Units)

Table 32. Europe Bacteriophages Antimicrobials Sales by Country (2026-2031) & (K Units)

Table 33. Europe Bacteriophages Antimicrobials Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Bacteriophages Antimicrobials Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Bacteriophages Antimicrobials Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Bacteriophages Antimicrobials Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Bacteriophages Antimicrobials Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Bacteriophages Antimicrobials Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Bacteriophages Antimicrobials Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Bacteriophages Antimicrobials Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Bacteriophages Antimicrobials Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Bacteriophages Antimicrobials Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Bacteriophages Antimicrobials Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Bacteriophages Antimicrobials Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Bacteriophages Antimicrobials Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Bacteriophages Antimicrobials Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Bacteriophages Antimicrobials Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Bacteriophages Antimicrobials Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Bacteriophages Antimicrobials Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Bacteriophages Antimicrobials Sales (K Units) by Type (2020-2025)

Table 51. Global Bacteriophages Antimicrobials Sales (K Units) by Type (2026-2031)

Table 52. Global Bacteriophages Antimicrobials Sales Market Share by Type (2020-2025)

Table 53. Global Bacteriophages Antimicrobials Sales Market Share by Type (2026-2031)

Table 54. Global Bacteriophages Antimicrobials Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Bacteriophages Antimicrobials Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Bacteriophages Antimicrobials Revenue Market Share by Type (2020-2025)

Table 57. Global Bacteriophages Antimicrobials Revenue Market Share by Type (2026-2031)

Table 58. Global Bacteriophages Antimicrobials Price (US$/Unit) by Type (2020-2025)

Table 59. Global Bacteriophages Antimicrobials Price (US$/Unit) by Type (2026-2031)

Table 60. Global Bacteriophages Antimicrobials Sales (K Units) by Application (2020-2025)

Table 61. Global Bacteriophages Antimicrobials Sales (K Units) by Application (2026-2031)

Table 62. Global Bacteriophages Antimicrobials Sales Market Share by Application (2020-2025)

Table 63. Global Bacteriophages Antimicrobials Sales Market Share by Application (2026-2031)

Table 64. Global Bacteriophages Antimicrobials Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Bacteriophages Antimicrobials Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Bacteriophages Antimicrobials Revenue Market Share by Application (2020-2025)

Table 67. Global Bacteriophages Antimicrobials Revenue Market Share by Application (2026-2031)

Table 68. Global Bacteriophages Antimicrobials Price (US$/Unit) by Application (2020-2025)

Table 69. Global Bacteriophages Antimicrobials Price (US$/Unit) by Application (2026-2031)

Table 70. Vésale Bioscience Company Information

Table 71. Vésale Bioscience Description and Business Overview

Table 72. Vésale Bioscience Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Vésale Bioscience Bacteriophages Antimicrobials Product

Table 74. Vésale Bioscience Recent Developments/Updates

Table 75. Adaptive Phage Therapeutics Company Information

Table 76. Adaptive Phage Therapeutics Description and Business Overview

Table 77. Adaptive Phage Therapeutics Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Adaptive Phage Therapeutics Bacteriophages Antimicrobials Product

Table 79. Adaptive Phage Therapeutics Recent Developments/Updates

Table 80. Proteon Pharmaceuticals Company Information

Table 81. Proteon Pharmaceuticals Description and Business Overview

Table 82. Proteon Pharmaceuticals Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Proteon Pharmaceuticals Bacteriophages Antimicrobials Product

Table 84. Proteon Pharmaceuticals Recent Developments/Updates

Table 85. PHIOGEN Company Information

Table 86. PHIOGEN Description and Business Overview

Table 87. PHIOGEN Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. PHIOGEN Bacteriophages Antimicrobials Product

Table 89. PHIOGEN Recent Developments/Updates

Table 90. Phageguard Company Information

Table 91. Phageguard Description and Business Overview

Table 92. Phageguard Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Phageguard Bacteriophages Antimicrobials Product

Table 94. Phageguard Recent Developments/Updates

Table 95. Armata Pharmaceuticals Company Information

Table 96. Armata Pharmaceuticals Description and Business Overview

Table 97. Armata Pharmaceuticals Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Armata Pharmaceuticals Bacteriophages Antimicrobials Product

Table 99. Armata Pharmaceuticals Recent Developments/Updates

Table 100. ACD Pharmaceuticals Company Information

Table 101. ACD Pharmaceuticals Description and Business Overview

Table 102. ACD Pharmaceuticals Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. ACD Pharmaceuticals Bacteriophages Antimicrobials Product

Table 104. ACD Pharmaceuticals Recent Developments/Updates

Table 105. SyntBioLab Company Information

Table 106. SyntBioLab Description and Business Overview

Table 107. SyntBioLab Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. SyntBioLab Bacteriophages Antimicrobials Product

Table 109. SyntBioLab Recent Developments/Updates

Table 110. Antibody Design Labs Company Information

Table 111. Antibody Design Labs Description and Business Overview

Table 112. Antibody Design Labs Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Antibody Design Labs Bacteriophages Antimicrobials Product

Table 114. Antibody Design Labs Recent Developments/Updates

Table 115. APS Biocontrol Company Information

Table 116. APS Biocontrol Description and Business Overview

Table 117. APS Biocontrol Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. APS Biocontrol Bacteriophages Antimicrobials Product

Table 119. APS Biocontrol Recent Developments/Updates

Table 120. BiomX Company Information

Table 121. BiomX Description and Business Overview

Table 122. BiomX Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. BiomX Bacteriophages Antimicrobials Product

Table 124. BiomX Recent Developments/Updates

Table 125. EcoPhage Company Information

Table 126. EcoPhage Description and Business Overview

Table 127. EcoPhage Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. EcoPhage Bacteriophages Antimicrobials Product

Table 129. EcoPhage Recent Developments/Updates

Table 130. Ecolyse Company Information

Table 131. Ecolyse Description and Business Overview

Table 132. Ecolyse Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Ecolyse Bacteriophages Antimicrobials Product

Table 134. Ecolyse Recent Developments/Updates

Table 135. Fixed Phage Company Information

Table 136. Fixed Phage Description and Business Overview

Table 137. Fixed Phage Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Fixed Phage Bacteriophages Antimicrobials Product

Table 139. Fixed Phage Recent Developments/Updates

Table 140. Intralytix Company Information

Table 141. Intralytix Description and Business Overview

Table 142. Intralytix Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Intralytix Bacteriophages Antimicrobials Product

Table 144. Intralytix Recent Developments/Updates

Table 145. Locus Biosciences Company Information

Table 146. Locus Biosciences Description and Business Overview

Table 147. Locus Biosciences Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. Locus Biosciences Bacteriophages Antimicrobials Product

Table 149. Locus Biosciences Recent Developments/Updates

Table 150. Micreos Company Information

Table 151. Micreos Description and Business Overview

Table 152. Micreos Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. Micreos Bacteriophages Antimicrobials Product

Table 154. Micreos Recent Developments/Updates

Table 155. OmniLytics Company Information

Table 156. OmniLytics Description and Business Overview

Table 157. OmniLytics Bacteriophages Antimicrobials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 158. OmniLytics Bacteriophages Antimicrobials Product

Table 159. OmniLytics Recent Developments/Updates

Table 160. Key Raw Materials Lists

Table 161. Raw Materials Key Suppliers Lists

Table 162. Bacteriophages Antimicrobials Distributors List

Table 163. Bacteriophages Antimicrobials Customers List

Table 164. Bacteriophages Antimicrobials Market Trends

Table 165. Bacteriophages Antimicrobials Market Drivers

Table 166. Bacteriophages Antimicrobials Market Challenges

Table 167. Bacteriophages Antimicrobials Market Restraints

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

Table 171. Authors List of This Report

List of Figures

Figure 1. Product Picture of Bacteriophages Antimicrobials

Figure 2. Global Bacteriophages Antimicrobials Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Bacteriophages Antimicrobials Market Share by Type: 2024 & 2031

Figure 4. by End Users Product Picture

Figure 5. by Genome Product Picture

Figure 6. Global Bacteriophages Antimicrobials Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Bacteriophages Antimicrobials Market Share by Application: 2024 & 2031

Figure 8. Medical

Figure 9. Food Industry

Figure 10. Agriculture

Figure 11. Others

Figure 12. Global Bacteriophages Antimicrobials Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Bacteriophages Antimicrobials Market Size (2020-2031) & (US$ Million)

Figure 14. Global Bacteriophages Antimicrobials Sales (2020-2031) & (K Units)

Figure 15. Global Bacteriophages Antimicrobials Average Price (US$/Unit) & (2020-2031)

Figure 16. Bacteriophages Antimicrobials Report Years Considered

Figure 17. Bacteriophages Antimicrobials Sales Share by Manufacturers in 2024

Figure 18. Global Bacteriophages Antimicrobials Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Bacteriophages Antimicrobials Players: Market Share by Revenue in Bacteriophages Antimicrobials in 2024

Figure 20. Bacteriophages Antimicrobials Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Bacteriophages Antimicrobials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Bacteriophages Antimicrobials Sales Market Share by Country (2020-2031)

Figure 23. North America Bacteriophages Antimicrobials Revenue Market Share by Country (2020-2031)

Figure 24. United States Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Bacteriophages Antimicrobials Sales Market Share by Country (2020-2031)

Figure 27. Europe Bacteriophages Antimicrobials Revenue Market Share by Country (2020-2031)

Figure 28. Germany Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Bacteriophages Antimicrobials Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Bacteriophages Antimicrobials Revenue Market Share by Region (2020-2031)

Figure 35. China Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Bacteriophages Antimicrobials Sales Market Share by Country (2020-2031)

Figure 43. Latin America Bacteriophages Antimicrobials Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Bacteriophages Antimicrobials Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Bacteriophages Antimicrobials Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Bacteriophages Antimicrobials Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Bacteriophages Antimicrobials by Type (2020-2031)

Figure 53. Global Revenue Market Share of Bacteriophages Antimicrobials by Type (2020-2031)

Figure 54. Global Bacteriophages Antimicrobials Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Bacteriophages Antimicrobials by Application (2020-2031)

Figure 56. Global Revenue Market Share of Bacteriophages Antimicrobials by Application (2020-2031)

Figure 57. Global Bacteriophages Antimicrobials Price (US$/Unit) by Application (2020-2031)

Figure 58. Bacteriophages Antimicrobials Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions